Not Yet RecruitingNot Applicable

Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis

China20 participantsStarted 2025-12-01

Plain-language summary

We compare two oral tinidazole regimens for refractory trichomonas vaginitis.

Who can participate

Age range18 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women be at least 18 years of age * Failure of conventional treatment (recommended by guidelines including tinidazole, 2g once daily for 5-7 days) Exclusion Criteria: * Allergy to metronidazole or tinidazol * Pregnant or nursing * HIV or other chronic disease

What they're measuring

Cure rate of refractory trichomoniasis

Timeframe: 24 weeks

Trial details

NCT IDNCT05383521

SponsorShangrong Fan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-30

Contact for this trial

Yiheng Liang, M.D.

86-755-83923333 13510331823@163.com

View on ClinicalTrials.gov More Trichomonas Vaginitis trials